Efficient synthesis and molecular docking studies of new pyrimidine-chromeno hybrid derivatives as potential antiproliferative agents
Yazarlar (5)
Doç. Dr. Sevtap Çağlar Yavuz Erciyes Üniversitesi, Türkiye
Prof. Dr. Senem Akkoç Süleyman Demirel Üniversitesi, Türkiye
Prof. Dr. Burak Tüzün Cumhuriyet Üniversitesi, Türkiye
Prof. Dr. Onur ŞAHİN Sinop Üniversitesi, Türkiye
Prof. Dr. Emin Sarıpınar Erciyes Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Synthetic Communications (Q2)
Dergi ISSN 0039-7911 Dergi Bilgileri (2021)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2021
Kabul Tarihi Yayınlanma Tarihi 26-05-2021
Cilt / Sayı / Sayfa 51 / 14 / 2135–2159 DOI 10.1080/00397911.2021.1922920
Makale Linki http://dx.doi.org/10.1080/00397911.2021.1922920
UAK Araştırma Alanları
Yoğun Madde Fiziği
Özet
Various novel heterocyclic compounds containing pyrimidine nuclei 5H-chromeno[4,3-d]pyrimidine (4a–c, e–h, l–r, t) and pyrimidine-5-yl-(2-hydroxyphenyl)methanone (5a, c, d, f–k, m–o, r, s, u) were synthesized from the reaction of guanylhydrazones (2a–u) and 3-formylchromone (3). These compounds were tested against human liver hepatocellular carcinoma cell line (HepG2) and human breast adenocarcinoma cell line (MDA-MB-231) using the MTT assay method. Furthermore, molecular docking calculations were performed to compare the biological activities of various novel heterocyclic compounds against cancer proteins. In these calculations, the protein used are crystal structure of the BRCT repeat region from the breast cancer associated protein, 1JNX, crystal structure of VEGFR kinase (liver cancer) protein, 3WZE, and crystal structure of an allosteric Eya2 phosphates inhibitor (lung cancer) protein, 5ZMA …
Anahtar Kelimeler
Antiproliferative activity | HepG2 | MDA-MB-231 | molecular docking | pyrimidine
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 20
Scopus 21
Google Scholar 34
Efficient synthesis and molecular docking studies of new pyrimidine-chromeno hybrid derivatives as potential antiproliferative agents

Paylaş